| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inhibitor of Differentiation Proteins | 19 | 2017 | 28 | 7.680 |
Why?
|
| Prostatic Neoplasms | 23 | 2017 | 794 | 4.920 |
Why?
|
| Sertoli Cells | 15 | 2005 | 43 | 2.590 |
Why?
|
| Prostate | 6 | 2016 | 136 | 2.030 |
Why?
|
| Receptors, Androgen | 7 | 2017 | 122 | 1.880 |
Why?
|
| Follicle Stimulating Hormone | 11 | 2004 | 41 | 1.770 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 8 | 2019 | 9 | 1.690 |
Why?
|
| Promoter Regions, Genetic | 15 | 2014 | 484 | 1.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2017 | 781 | 1.550 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2019 | 79 | 1.420 |
Why?
|
| Apoptosis | 12 | 2017 | 1317 | 1.390 |
Why?
|
| Cell Line, Tumor | 22 | 2020 | 2128 | 1.330 |
Why?
|
| Neoplasm Proteins | 5 | 2017 | 203 | 1.240 |
Why?
|
| Transcription Factors | 9 | 2013 | 653 | 1.170 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 5 | 2015 | 7 | 1.170 |
Why?
|
| Helix-Loop-Helix Motifs | 8 | 2005 | 13 | 1.150 |
Why?
|
| Transferrin | 10 | 2002 | 31 | 1.130 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2018 | 41 | 1.070 |
Why?
|
| Doxorubicin | 3 | 2018 | 80 | 1.040 |
Why?
|
| Lysine | 2 | 2017 | 104 | 1.030 |
Why?
|
| Male | 50 | 2020 | 18870 | 1.020 |
Why?
|
| Cell Differentiation | 16 | 2014 | 562 | 1.000 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 200 | 0.990 |
Why?
|
| DNA-Binding Proteins | 9 | 2012 | 522 | 0.960 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 550 | 0.800 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2012 | 58 | 0.780 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 242 | 0.770 |
Why?
|
| Epithelial Cells | 5 | 2012 | 366 | 0.750 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2017 | 41 | 0.730 |
Why?
|
| Cell Cycle | 5 | 2014 | 309 | 0.720 |
Why?
|
| Gene Expression Regulation | 10 | 2010 | 968 | 0.710 |
Why?
|
| Gene Silencing | 4 | 2014 | 143 | 0.710 |
Why?
|
| Taxoids | 2 | 2016 | 36 | 0.650 |
Why?
|
| Cell Proliferation | 11 | 2019 | 1149 | 0.650 |
Why?
|
| Animals | 33 | 2020 | 14307 | 0.640 |
Why?
|
| Humans | 39 | 2020 | 34853 | 0.640 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2014 | 184 | 0.620 |
Why?
|
| Repressor Proteins | 3 | 2005 | 226 | 0.620 |
Why?
|
| Rats | 23 | 2020 | 3261 | 0.620 |
Why?
|
| Transfection | 10 | 2014 | 496 | 0.610 |
Why?
|
| Testis | 5 | 2014 | 185 | 0.580 |
Why?
|
| Nanoparticles | 3 | 2020 | 294 | 0.570 |
Why?
|
| Cell Division | 2 | 2014 | 296 | 0.540 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 638 | 0.530 |
Why?
|
| Growth and Development | 1 | 2014 | 8 | 0.520 |
Why?
|
| Testosterone | 3 | 2014 | 181 | 0.490 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 10 | 0.490 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 209 | 0.480 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2009 | 605 | 0.480 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2013 | 13 | 0.470 |
Why?
|
| Histones | 1 | 2014 | 177 | 0.460 |
Why?
|
| Interleukin-6 | 1 | 2014 | 140 | 0.460 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 53 | 0.460 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 21 | 0.440 |
Why?
|
| Drug Carriers | 3 | 2020 | 121 | 0.440 |
Why?
|
| Inflammation | 2 | 2008 | 577 | 0.440 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 128 | 0.430 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 239 | 0.420 |
Why?
|
| Androgens | 3 | 2010 | 87 | 0.420 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2011 | 6 | 0.410 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 1490 | 0.400 |
Why?
|
| Base Sequence | 10 | 2005 | 932 | 0.380 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2001 | 50 | 0.370 |
Why?
|
| Mice, Nude | 4 | 2019 | 323 | 0.370 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 298 | 0.370 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 43 | 0.360 |
Why?
|
| Cell Survival | 4 | 2018 | 818 | 0.340 |
Why?
|
| Calcitonin | 1 | 2008 | 5 | 0.340 |
Why?
|
| Mice | 9 | 2019 | 5668 | 0.340 |
Why?
|
| RNA, Messenger | 7 | 2013 | 1152 | 0.340 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 247 | 0.330 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 145 | 0.320 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 211 | 0.310 |
Why?
|
| Cells, Cultured | 10 | 2009 | 1442 | 0.290 |
Why?
|
| Mice, SCID | 2 | 2017 | 143 | 0.290 |
Why?
|
| Chromosomal Instability | 1 | 2006 | 21 | 0.290 |
Why?
|
| Polyesters | 2 | 2016 | 21 | 0.280 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2012 | 54 | 0.280 |
Why?
|
| Polysaccharides | 2 | 2016 | 55 | 0.270 |
Why?
|
| Case-Control Studies | 3 | 2014 | 1056 | 0.270 |
Why?
|
| Acetylation | 2 | 2017 | 94 | 0.270 |
Why?
|
| Tumor Burden | 2 | 2016 | 79 | 0.270 |
Why?
|
| DNA Methylation | 3 | 2014 | 301 | 0.260 |
Why?
|
| Neoplasms | 1 | 2014 | 1033 | 0.260 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 391 | 0.250 |
Why?
|
| RNA Interference | 2 | 2016 | 225 | 0.240 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2005 | 38 | 0.230 |
Why?
|
| Gene Expression | 5 | 2013 | 639 | 0.220 |
Why?
|
| Response Elements | 2 | 2001 | 52 | 0.220 |
Why?
|
| Phenotype | 2 | 2017 | 650 | 0.220 |
Why?
|
| Zinc Fingers | 1 | 2002 | 25 | 0.210 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 287 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1999 | 74 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2014 | 1534 | 0.210 |
Why?
|
| Mice, Knockout | 2 | 2014 | 897 | 0.200 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 1124 | 0.200 |
Why?
|
| Docosahexaenoic Acids | 1 | 2020 | 18 | 0.200 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2020 | 21 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 184 | 0.190 |
Why?
|
| Mutation | 2 | 2017 | 1023 | 0.190 |
Why?
|
| Trans-Activators | 1 | 2001 | 167 | 0.190 |
Why?
|
| Titanium | 1 | 2020 | 34 | 0.190 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2000 | 72 | 0.190 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 600 | 0.190 |
Why?
|
| Proteins | 2 | 2009 | 352 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2002 | 287 | 0.180 |
Why?
|
| Signal Transduction | 1 | 2008 | 1802 | 0.180 |
Why?
|
| Light | 1 | 2020 | 180 | 0.180 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 61 | 0.180 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 47 | 0.180 |
Why?
|
| Genes, fos | 2 | 1996 | 14 | 0.180 |
Why?
|
| Consensus Sequence | 1 | 1999 | 24 | 0.180 |
Why?
|
| Sepharose | 1 | 2018 | 14 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 528 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2007 | 834 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2010 | 29 | 0.170 |
Why?
|
| Down-Regulation | 2 | 2012 | 420 | 0.170 |
Why?
|
| Delayed-Action Preparations | 1 | 2018 | 57 | 0.170 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 122 | 0.170 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 41 | 0.170 |
Why?
|
| Hydrogels | 1 | 2018 | 33 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 147 | 0.170 |
Why?
|
| Ulva | 1 | 2018 | 7 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 859 | 0.160 |
Why?
|
| Trophoblasts | 3 | 1992 | 22 | 0.160 |
Why?
|
| Ferrous Compounds | 1 | 2018 | 20 | 0.160 |
Why?
|
| Nanocomposites | 1 | 2018 | 19 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 195 | 0.160 |
Why?
|
| Water Purification | 1 | 2018 | 27 | 0.160 |
Why?
|
| Cyclic AMP | 4 | 2001 | 125 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 10 | 0.150 |
Why?
|
| Graphite | 1 | 2018 | 50 | 0.150 |
Why?
|
| Anilides | 1 | 2017 | 27 | 0.150 |
Why?
|
| Cyclohexanes | 1 | 2017 | 29 | 0.150 |
Why?
|
| Cloning, Molecular | 3 | 2004 | 310 | 0.150 |
Why?
|
| Cell Shape | 2 | 2013 | 35 | 0.150 |
Why?
|
| Protein Isoforms | 2 | 2007 | 121 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 161 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 164 | 0.140 |
Why?
|
| Chorionic Gonadotropin | 3 | 1992 | 13 | 0.140 |
Why?
|
| Blotting, Northern | 3 | 2002 | 139 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2013 | 1961 | 0.140 |
Why?
|
| Protein Transport | 1 | 2017 | 286 | 0.140 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 158 | 0.140 |
Why?
|
| Intracellular Space | 1 | 2015 | 35 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2017 | 351 | 0.130 |
Why?
|
| Sequence Homology | 1 | 2014 | 34 | 0.130 |
Why?
|
| Progesterone | 2 | 1992 | 117 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 25 | 0.130 |
Why?
|
| Genetic Loci | 1 | 2015 | 70 | 0.130 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 114 | 0.120 |
Why?
|
| Seminiferous Epithelium | 1 | 2014 | 5 | 0.120 |
Why?
|
| Tubulin | 1 | 2014 | 80 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 485 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 114 | 0.120 |
Why?
|
| Nandrolone | 2 | 1990 | 6 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2013 | 1 | 0.120 |
Why?
|
| Protein Binding | 1 | 2017 | 913 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2013 | 17 | 0.120 |
Why?
|
| Vimentin | 1 | 2013 | 32 | 0.120 |
Why?
|
| Fertility | 2 | 1990 | 59 | 0.120 |
Why?
|
| Spermatids | 1 | 2013 | 42 | 0.120 |
Why?
|
| Cadherins | 1 | 2013 | 82 | 0.120 |
Why?
|
| Spermatogonia | 1 | 2014 | 56 | 0.120 |
Why?
|
| Antigens, CD | 1 | 2013 | 116 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 649 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 102 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 198 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 91 | 0.100 |
Why?
|
| Phylogeny | 1 | 2014 | 612 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 245 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2013 | 517 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 283 | 0.100 |
Why?
|
| DNA, Complementary | 2 | 2004 | 175 | 0.100 |
Why?
|
| Genitalia, Male | 1 | 1990 | 12 | 0.100 |
Why?
|
| Contraceptive Agents, Male | 1 | 1990 | 3 | 0.100 |
Why?
|
| Hormones | 1 | 1990 | 51 | 0.100 |
Why?
|
| Agar | 1 | 2010 | 8 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 12 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 878 | 0.090 |
Why?
|
| Karyotyping | 1 | 2010 | 46 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 87 | 0.090 |
Why?
|
| Logistic Models | 1 | 2013 | 894 | 0.090 |
Why?
|
| Telomerase | 1 | 2010 | 40 | 0.090 |
Why?
|
| Genomics | 1 | 2011 | 201 | 0.090 |
Why?
|
| Cell Line | 2 | 2019 | 1289 | 0.090 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1999 | 22 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 2 | 2004 | 455 | 0.090 |
Why?
|
| Adsorption | 2 | 2020 | 67 | 0.090 |
Why?
|
| Bucladesine | 2 | 2001 | 7 | 0.090 |
Why?
|
| Phytosterols | 1 | 2009 | 3 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 115 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 756 | 0.090 |
Why?
|
| Prostatic Hyperplasia | 1 | 2009 | 33 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 480 | 0.090 |
Why?
|
| Cell Movement | 1 | 2012 | 545 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2002 | 132 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2009 | 42 | 0.090 |
Why?
|
| Receptors, Calcitonin | 1 | 2008 | 3 | 0.090 |
Why?
|
| RNA, Catalytic | 1 | 2008 | 5 | 0.090 |
Why?
|
| Adult | 2 | 2014 | 11034 | 0.090 |
Why?
|
| Genotype | 1 | 2011 | 641 | 0.090 |
Why?
|
| Dependovirus | 1 | 2008 | 11 | 0.090 |
Why?
|
| Flow Cytometry | 2 | 2009 | 392 | 0.080 |
Why?
|
| Middle Aged | 2 | 2014 | 9642 | 0.080 |
Why?
|
| Binding Sites | 3 | 2000 | 597 | 0.080 |
Why?
|
| Kinetics | 2 | 2018 | 650 | 0.080 |
Why?
|
| Computational Biology | 1 | 2010 | 275 | 0.080 |
Why?
|
| Cholesterol | 1 | 2009 | 194 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2333 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2008 | 209 | 0.080 |
Why?
|
| DNA | 3 | 2000 | 549 | 0.070 |
Why?
|
| Lipoproteins, LDL | 2 | 2020 | 61 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2006 | 8 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2006 | 8 | 0.070 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 18 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2006 | 12 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 19 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2006 | 14 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 608 | 0.070 |
Why?
|
| Genomic Instability | 1 | 2006 | 34 | 0.070 |
Why?
|
| Epithelium | 1 | 2006 | 74 | 0.070 |
Why?
|
| Metribolone | 1 | 2005 | 3 | 0.070 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 24 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 136 | 0.060 |
Why?
|
| Adolescent | 1 | 2014 | 5035 | 0.060 |
Why?
|
| RNA | 2 | 2009 | 234 | 0.060 |
Why?
|
| Spermatogenesis | 2 | 2014 | 154 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2002 | 17 | 0.050 |
Why?
|
| Aged | 1 | 2014 | 6448 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 26 | 0.050 |
Why?
|
| Gene Library | 1 | 2002 | 55 | 0.050 |
Why?
|
| Immunosorbent Techniques | 1 | 2001 | 3 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2001 | 9 | 0.050 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2020 | 1 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2000 | 19 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 70 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2020 | 197 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2000 | 67 | 0.050 |
Why?
|
| Catalysis | 1 | 2020 | 162 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2000 | 74 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2000 | 257 | 0.050 |
Why?
|
| HCT116 Cells | 1 | 2019 | 34 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 1999 | 10 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 984 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 1999 | 48 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 45 | 0.040 |
Why?
|
| Protein Folding | 1 | 2020 | 121 | 0.040 |
Why?
|
| Seaweed | 1 | 2018 | 11 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 195 | 0.040 |
Why?
|
| Anions | 1 | 2018 | 39 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 52 | 0.040 |
Why?
|
| Vero Cells | 1 | 2018 | 90 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 1998 | 2 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 123 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2018 | 70 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 27 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1998 | 31 | 0.040 |
Why?
|
| Chromium | 1 | 2018 | 27 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 467 | 0.040 |
Why?
|
| Bronchi | 1 | 1998 | 45 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2018 | 51 | 0.040 |
Why?
|
| Liver | 1 | 2020 | 447 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1998 | 122 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 342 | 0.040 |
Why?
|
| Female | 6 | 2019 | 19873 | 0.040 |
Why?
|
| TCF Transcription Factors | 1 | 1997 | 14 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1998 | 166 | 0.040 |
Why?
|
| Lead | 1 | 2018 | 87 | 0.040 |
Why?
|
| Dimerization | 1 | 1997 | 102 | 0.040 |
Why?
|
| Testicular Hormones | 1 | 1995 | 1 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1530 | 0.030 |
Why?
|
| Receptor, erbB-3 | 1 | 2014 | 11 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1998 | 336 | 0.030 |
Why?
|
| Sperm Count | 2 | 1990 | 25 | 0.030 |
Why?
|
| Sperm Motility | 2 | 1990 | 37 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2015 | 150 | 0.030 |
Why?
|
| Sperm Maturation | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 91 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2013 | 27 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2013 | 29 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 26 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 79 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 1992 | 2 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 2012 | 23 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 200 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1992 | 29 | 0.030 |
Why?
|
| Secretory Rate | 1 | 1992 | 2 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1992 | 13 | 0.030 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 1992 | 7 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1992 | 23 | 0.030 |
Why?
|
| Giant Cells | 1 | 1992 | 13 | 0.030 |
Why?
|
| Proteome | 1 | 2013 | 132 | 0.030 |
Why?
|
| Proteomics | 1 | 2013 | 302 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1990 | 62 | 0.020 |
Why?
|
| Estradiol | 1 | 1992 | 244 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1990 | 13 | 0.020 |
Why?
|
| Progestins | 1 | 1990 | 14 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1992 | 282 | 0.020 |
Why?
|
| Random Allocation | 1 | 1990 | 139 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 642 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 19 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2009 | 33 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2009 | 67 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2009 | 27 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 269 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 188 | 0.020 |
Why?
|
| Mitochondria | 1 | 1992 | 454 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 639 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 1300 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1998 | 14 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 1998 | 27 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 40 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1998 | 91 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 73 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 121 | 0.010 |
Why?
|
| Pregnancy | 2 | 1992 | 1503 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1998 | 229 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 103 | 0.010 |
Why?
|
| Placenta | 1 | 1992 | 91 | 0.010 |
Why?
|
| Glycerylphosphorylcholine | 1 | 1990 | 1 | 0.010 |
Why?
|
| Acrosin | 1 | 1990 | 2 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1990 | 20 | 0.010 |
Why?
|
| Sperm-Ovum Interactions | 1 | 1990 | 13 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1990 | 19 | 0.010 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1990 | 19 | 0.010 |
Why?
|
| Fructose | 1 | 1990 | 23 | 0.010 |
Why?
|
| Semen | 1 | 1990 | 48 | 0.010 |
Why?
|
| Rabbits | 1 | 1990 | 278 | 0.010 |
Why?
|
| Spermatozoa | 1 | 1990 | 191 | 0.010 |
Why?
|